drugset / Trial / NCT07151391

The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)

NCT07151391 ↗

Phase 2 Recruiting 86 enrolled University of Utah
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this clinical trial is to learn if the drug guarana improves symptoms of fatigue in patients with neuroendocrine tumors and gynecologic cancers

Timeline

Start
2025-09-03
Primary completion
2027-09
Completion
2028-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaraná Traditional medicine (herbal / TCM) 500 mg Oral